Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage i non-small cell lung cancer treated with stereotactic body radiation therapy

European Journal of Radiology

Volumn 81, Issue 11, 2012, Pages 3530-3534

  Satoh, Yoko ^a   Nambu, Atsushi ^b   Onishi, Hiroshi ^b   Sawada, Eiichi ^b   Tominaga, Licht ^b   Kuriyama, Kengo ^b   Komiyama, Takafumi ^c   Marino, Kan ^d   Aoki, Shinichi ^b   Araya, Masayuki ^b   Saito, Ryo ^b   Maehata, Yoshiyasu ^b   Oguri, Mitsuhiko ^b   Araki, Tsutomu ^b  

^a Kofu Neurosurgical Hospital   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c Kofu Municipal Hospital   (Japan)

^d Yamanashi Prefectural Central Hospital   (Japan)

Author keywords

Dual time point FDG PET; FDG PET CT; Non small cell lung cancer; Prognosis; Stereotactic body radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STEREOTACTIC BODY RADIATION THERAPY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOSURGERY; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84866998913     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.11.047     Document Type: Article

References (20)

1. J.W. Song, Y.M. Oh, T.S. Shim, W.S. Kim, J.S. Ryu, and C.M. Choi Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer Lung Cancer 65 2009 333 338
2. M. Paesmans, T. Berghmans, and M. Dusart Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer staging Project J Thorac Oncol 5 2010 612 619
3. M.M. Sathekge, A. Maes, H. Pottel, A. Stoltz, and C. van de Wiele Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area S Afr Med J 7 2010 598 601
4. B. Sanghera, W.L. Wong, and M.A. Lodge Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer Nucl Med Commun 26 2005 861 867
5. D.Y. Song, B.D. Kavanagh, S.H. Benedict, and T. Schefter Stereotactic body radiation therapy. Rationael, techniques, applications, and optimization Oncology (Williston Park) 18 2004 1419 1430 discussion 1432-1430, 1435-6
6. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
7. I.C. Okereke, S.P. Gangadharan, M.S. Kent, S.P. Nicotera, C. Shen, and M.M. DeCamp Standard uptake value predicts survival in non-small cell lung cancer Ann Thorac Surg 88 2009 911 915
8. D.J. Hoopes, M. Tann, and J.W. Fletcher FDG-PET and stereotactic body radiotherapy (SRBT) for stage I non-small-cell lung cancer Lung Cancer 56 2007 229 234
9. M.J. Burdick, K.L. Stephans, C.A. Reddy, T. Djemil, S.M. Srinivas, and G.M. Videtic Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 78 2010 1033 1039
10. K. Higashi, Y. Ueda, and Y. Arisaka 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer J Nucl Med 43 2002 39 45
11. T. Ohtsuka, H. Nomori, and K. Watanabe Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma Cancer 107 2006 2468 2473
12. C. Casali, M. Cucca, and G. Rossi The variation of prognostic significance of maximum standardized uptake value of [18F]-fluoro-2-deoxy- glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected non-small cell lung carcinoma Lung Cancer 69 2010 187 193
13. K. Macdonald, J. Searie, and I. Lyburn The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5 Clin Radiol 66 2011 244 250
14. D. Uesaka, Y. Demura, and T. Ishizaki Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer J Nucl Med 49 2008 1606 1612
15. A. Lyshchik, T. Higashi, and Y. Nakamoto Dual-phase 18F-fluoro-2-deoxy-d- glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer Eur J Nucl Mol Imaging 32 2005 389 397
16. S.J. Kim, Y.K. Kim, I.J. Kim, Y.D. Kim, and M.K. Lee Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) non-small cell lung cancer (NSCLC) Radiother Oncol 98 2011 105 108
17. T. Mochizuki, E. Tsukamoto, and Y. Kuge FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models J Nucl Med 43 2001 1551 1555
18. V. Ambrosini, S. Nicolini, and P. Caroli PET/CT imaging in different types of lung cancer: an overview Eur J Radiol 2011
19. M. Li, N. Wu, and Y. Liu Regional nodal staging with (18)F-FDG PET-CT in non-small cell lung cancer: additional diagnostic value of CT attenuation and dual-time-point imaging Eur J Radiol 2011
20. H. Onishi, T. Araki, and H. Shirato Stereotactic Hypofractionated high-dose irradiation for stage I nonsmall cell lung cancer, Clinical outcomes in 245 subjects in a Japanese Multistitutional Study Cancer 101 2004 1623 1631